Ameloblastoma, the second most common odontogenic tumor, is also one of the most documented and extensively researched benign tumor affecting the maxillofacial region. Usually diagnosed between 30 and 60 years of age, it accounts for about 1% of …

Ameloblastoma is the most common benign epithelial odontogenic tumor of the jaws. It occurs mostly in the mandibular posterior region. Recurrence is more common in the mandible than the maxilla and in the follicular type than plexiform or other …

Ameloblastic carcinoma is one of the rarest malignant neoplasm originating from odontogenic epithelium[ 1 ]. Limited number of cases have been reported in the literature. Clinically, it presents as a locally destructive, fast-growing, painful …

Ameloblastoma is a benign epithelial odontogenic tumor and represents one of the most clinically relevant neoplasms of odontogenic origin [ 1 , 2 ]. In accordance with the 5th Edition of the Classification of Head and Neck Tumors by the World …

Ameloblastoma is a rare odontogenic tumor which may be complicated by hypercalcemia in advanced disease. Tumoral parathyroid hormone-related peptide (PTHrP) production and local osteolysis from paracrine factors have been proposed as mechanisms.

Collision tumours, characterized by the simultaneous occurrence of two distinct neoplasms within the same anatomical site, are exceedingly rare in oral pathology. This case report presents an uncommon collision tumour involving desmoplastic …

Ameloblastoma is the second most common benign odontogenic neoplasm of which 1–1.3% undergo malignant transformation [ 1 , 2 ]. Synovial sarcomas are a unique subset of soft tissue sarcomas accounting for 5–10% cases [ 3 ]. Transformation to such …

Ameloblastoma is the most common aggressive benign odontogenic tumour of the jaws. Ameloblastoma is a benign epithelial odontogenic tumour that typically arises in the mandible or maxilla. A clinical, radiographic and histopathological report is …

Ameloblastoma is a benign epithelial odontogenic tumour that commonly originates from the dental lamina, epithelial rest cells of Malassez, and the basal cell layer of the oral epithelium (Xiong et al. 2022 ). It accounts for approximately 1% of …

Adenoid ameloblastoma (AdAM) is a unique type of tumor that shows hybrid histological features of both ameloblastoma and adenomatoid odontogenic tumor (AOT) but has higher recurrence rate than ameloblastoma and AOT [ 1 , 2 ]. The latest WHO …

Hypoxia-inducible factor-1α is a transcriptional protein that has been extensively researched in human cancers whose overexpression is found to be associated with unfavorable prognosis. Contemporary studies have proved its vital role in …

Ameloblastoma is a benign epithelial odontogenic tumor [ 1 ] originally described in 1827 by Cuzack and the publication of further details in 1868 by Broca [ 2 ]. It accounts for 13 to 58% of all odontogenic tumors [ 3 ], with an incidence rate of …